Endothelial Progenitor Cells and Their Clinical Applications as Potential Disease Biomarkers and Therapeutic Agents: Evidence and Controversies Regarding Their Effectiveness
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-319-55107-4_2
Reference67 articles.
1. Alba AC, Lalonde SD, Rao V, Walter SD, Guyatt GH, Ross HJ (2013) Changes in circulating progenitor cells are associated with outcome in heart failure patients: a longitudinal study. Can J Cardiol 29:1657–1664
2. Altabas V (2015) Diabetes, endothelial dysfunction, and vascular repair: what should a diabetologist keep his eye on? Int J Endocrinol 2015:848272. doi: 10.1155/2015/848272
3. Balistreri CR, Buffa S, Pisano C, Lio D, Ruvolo G, Mazzesi G (2015) Are endothelial progenitor cells the real solution for cardiovascular diseases? Focus on controversies and perspectives. BioMed Res Int 835934:1–18
4. Bogoslovsky (2010) Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology 75:2059–2062
5. Braitsch CM, Kanisicak O, van Berlo JH et al (2013) Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J Mol Cell Cardiol 65:108–119
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3